영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - terbutaline sulfate - nebuliser liquid - 2.5mg/1ml

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

astrazeneca ab - terbutaline sulfate - solution for injection/infusion - 500 microgram(s)/millilitre - selective beta-2-adrenoreceptor agonists; terbutaline

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

astrazeneca ab - terbutaline sulfate - inhalation powder - 500 mcg/acutuation - selective beta-2-adrenoreceptor agonists; terbutaline

몰타 - 영어 - Medicines Authority

astrazeneca ab se-151 85, södertälje, sweden - inhalation powder - terbutaline sulfate 500 µg/spray - drugs for obstructive airway diseases

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - terbutaline sulfate -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - terbutaline sulfate -

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - theophylline 250mg;  ; theophylline 250mg - modified release tablet - 250 mg - active: theophylline 250mg   excipient: cellacefate lactose monohydrate magnesium stearate active: theophylline 250mg excipient: guar gum magnesium stearate - nuelin-sr tablets are indicated for the relief and prophylaxis of reversible bronchospasm associated with asthma, chronic bronchitis and emphysema.

싱가포르 - 영어 - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - bambuterol hcl - tablet - 10 mg

캐나다 - 영어 - Health Canada

astrazeneca canada inc - terbutaline sulfate - powder (metered dose) - 0.5mg - terbutaline sulfate 0.5mg - selective beta 2-adrenergic agonists

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - budesonide, quantity: 0.25 mg/ml - inhalation, conventional - excipient ingredients: disodium edetate; sodium chloride; polysorbate 80; citric acid; sodium citrate dihydrate; water for injections - treatment of bronchial asthma. indications as approved 15 july 1997: treatment of bronchial asthma. pulmicort may also be used when replacement or reduction in oral steroid therapy is desirable. treatment of acute laryngotracheobronchitis (croup) in infants and children.